ProPhase Labs, Inc. Contractual Obligation, to be Paid, Year One
ProPhase Labs, Inc. (PRPH) had Contractual Obligation, to be Paid, Year One of $1.02 million as of 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Notes › Commitment and Contingencies › Contractual Obligation, Fiscal Year Maturity
us-gaap:ContractualObligationDueInNextTwelveMonths · last filed 2022-11-10
- 2022-09-30: Contractual Obligation, to be Paid, Year One $1.02M.
- 2022-06-30: Contractual Obligation, to be Paid, Year One $1.38M.
- 2022-03-31: Contractual Obligation, to be Paid, Year One $675.00K.
- 2021-12-31: Contractual Obligation, to be Paid, Year One $675.00K.
| Period end | Contractual Obligation, to be Paid, Year One |
|---|---|
| 2022-09-30 | $1.02M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $1.38M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $675.00K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $675.00K 10-K · filed 2022-03-31 |
| 2016-09-30 | $356.00K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $612.00K 10-Q · filed 2016-08-11 |
| 2016-03-31 | $869.00K 10-Q · filed 2016-05-13 |
| 2015-12-31 | $1.13M 10-K · filed 2016-03-29 |
| 2015-09-30 | $912.00K 10-Q · filed 2015-11-13 |
| 2015-06-30 | $912.00K 10-Q · filed 2015-08-12 |
| 2015-03-31 | $869.00K 10-Q · filed 2015-05-13 |
| 2014-12-31 | $1.13M 10-K · filed 2015-03-27 |
| 2014-09-30 | $356.00K 10-Q · filed 2014-11-13 |
| 2014-06-30 | $641.00K 10-Q · filed 2014-08-12 |
| 2014-03-31 | $1.13M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $1.13M 10-K · filed 2014-03-27 |
| 2013-09-30 | $356.00K 10-Q · filed 2013-11-13 |
| 2013-06-30 | $612.00K 10-Q · filed 2013-08-13 |
| 2013-03-31 | $869.00K 10-Q · filed 2013-05-10 |
| 2012-12-31 | $1.13M 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |